VanEck Associates’s Invesco IVZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69K Buy
2,824
+50
+2% +$1.31K ﹤0.01% 1323
2025
Q4
$73K Sell
2,774
-524
-16% -$12.8K ﹤0.01% 1339
2025
Q3
$76K Sell
3,298
-4,061
-55% -$84.3K ﹤0.01% 1334
2025
Q2
$116K Sell
7,359
-248
-3% -$3.56K ﹤0.01% 1295
2025
Q1
$115K Sell
7,607
-154,151
-95% -$2.63M ﹤0.01% 1268
2024
Q4
$2.83M Buy
161,758
+2,316
+1% +$41.2K ﹤0.01% 884
2024
Q3
$2.79M Buy
+159,442
New +$2.62M ﹤0.01% 840
2024
Q1
Sell
-8,967
Closed -$160K 1396
2023
Q4
$160K Sell
8,967
-3,386
-27% -$48.9K ﹤0.01% 1186
2023
Q3
$179K Sell
12,353
-8,251
-40% -$133K ﹤0.01% 1167
2023
Q2
$347K Buy
20,604
+8,197
+66% +$132K ﹤0.01% 1099
2023
Q1
$203K Buy
12,407
+2,313
+23% +$41.3K ﹤0.01% 1162
2022
Q4
$182K Buy
10,094
+537
+6% +$9.19K ﹤0.01% 1122
2022
Q3
$131K Buy
9,557
+3,927
+70% +$66.2K ﹤0.01% 1129
2022
Q2
$91K Buy
5,630
+1,405
+33% +$26.6K ﹤0.01% 1229
2022
Q1
$97K Buy
+4,225
New +$93.7K ﹤0.01% 1240

Other funds holding IVZ

VanEck Associates's IVZ Position: Q1 2026 in Review

VanEck Associates increased its Invesco (IVZ) stake by 1.8% in Q1 2026, buying an estimated $1.31K and bringing the position to 2,824 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #1323.

VanEck Associates first reported a position in IVZ in Q1 2022 and has held it in 15 quarters since. The position peaked at $2.83M in Q4 2024. 631 funds tracked by Wall St. Rank hold IVZ as of Q1 2026.

  • VanEck Associates held 2,824 shares of Invesco worth $69K as of Q1 2026.
  • VanEck Associates bought 50 Invesco shares in Q1 2026, an estimated $1.31K.
  • Invesco made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #1323 holding.
  • VanEck Associates first reported a position in Invesco in Q1 2022 and has held it in 15 quarters since.
  • VanEck Associates's Invesco position peaked at $2.83M in Q4 2024.
  • 631 funds tracked by Wall St. Rank held Invesco as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.